Condition: Kidney Disease, End-Stage · End-stage Renal Disease · Arteriovenous Fistula · Sponsor: C. R. Bard
A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.
This description comes directly from the study's public registry record.
Crystal Anderson · +16028305413 · Crystal.Anderson@bd.com
Always discuss trial participation with your own doctor first.
| California Institute of Renal Research | La Jolla, California, United States | Recruiting |
| San Francisco Vein & Vascular | San Francisco, California, United States | Recruiting |
| First Coast Cardiovascular Institute Pa | Jacksonville, Florida, United States | Recruiting |
| Radiology and Imaging Specialists | Lakeland, Florida, United States | Recruiting |
| Vascular and Spine Institute Inc | Miami, Florida, United States | Active Not Recruiting |
| Kidney Care and Transplant Services of NE | Springfield, Massachusetts, United States | Recruiting |
| Kidney Care & Transplant Services of New England | West Springfield, Massachusetts, United States | Recruiting |
| UMass Chan School of Medicine | Worcester, Massachusetts, United States | Recruiting |
| Albany Medical Center | Albany, New York, United States | Recruiting |
| NC Nephrology | Raleigh, North Carolina, United States | Completed |
| ProMedica Toledo Hospital | Toledo, Ohio, United States | Recruiting |
| Butler Memorial Hospital | Butler, Pennsylvania, United States | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04634916